{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:54:57Z","timestamp":1789084497780,"version":"build-2803163510"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Leukocyte chemotactic factor 2-associated (ALECT2) amyloidosis is one of the recently reported types of amyloidosis, which is caused by the extracellular deposition of leukocyte chemotactic factor 2 (LECT2). There have not been any reports involving the concurrence of ALECT2 amyloidosis with Sj\u00f6gren\u2019s syndrome (SS) or systemic lupus erythematosus (SLE)s. Herein, we report a case of a 68-year-old Chinese woman presenting with long duration of sicca symptoms. The clinical evaluation and laboratory findings showed that she had SS overlapped with SLE. Kidney biopsy revealed a membranoproliferative glomerulonephritis (MPGN) with glomerular deposition of dominant IgG3-kappa by immunofluorescene, which was related to SS\/SLE. Furthermore, patchy congophilic amyloid deposits in the tubulointerstitium were detected, which were positive for LECT2 protein by immunohistochemical staining and immunoelectron microscopy. This is the first case of ALECT2 amyloidosis that coexisted with SS\/SLE, and the causal relationship between ALECT2 amyloidosis and autoimmune diseases remain unclear.<\/jats:p>","DOI":"10.3389\/fimmu.2022.966591","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T05:59:17Z","timestamp":1660888757000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Concurrence of leukocyte chemotactic factor 2-associated amyloidosis and autoimmune diseases: A case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Shuang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12551214","article-title":"Leukocyte cell-derived chemotaxin 2-associated amyloidosis: A recently recognized disease with distinct clinicopathologic characteristics","volume":"10","author":"Nasr","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1722097","article-title":"Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients","volume":"27","author":"Li","year":"2020","journal-title":"Amyloid"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League against Rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League against Rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Eundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.20093","article-title":"Sj\u00f6gren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary sjogren's syndrome","volume":"50","author":"Manoussakis","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090804","article-title":"Secondary sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset","volume":"37","author":"Baer","year":"2010","journal-title":"J Rheumatol"},{"key":"B10","article-title":"Sjogren's syndrome in SLE: Part i. the frequency of the clinical and subclinical features of sjogren's syndrome in patients with SLE","volume":"86","author":"Grennan","year":"1977","journal-title":"N Z Med J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.08.007","article-title":"The overlap of sj\u00f6gren's syndrome with other systemic autoimmune diseases","volume":"36","author":"Ramos-Casals","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0720-0","article-title":"Clinical and laboratory profiles of systemic lupus erythematosus associated with sj\u00f6gren syndrome in China: a study of 542 patients","volume":"27","author":"Pan","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/art.39534","article-title":"Brief report: Monoclonal gammopathy and risk of lymphoma and multiple myeloma in patients with primary sj\u00f6gren's syndrome","volume":"68","author":"Tomi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.07.019","article-title":"Secondary renal amyloidosis due to long-standing tubulointerstitial nephritis in a patient with sj\u00f6gren syndrome","volume":"46","author":"Ooms","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12890\/2019_001226","article-title":"A rare case of renal AA amyloidosis secondary to sjogren's syndrome","volume":"6","author":"Costa","year":"2019","journal-title":"Eur J Case Rep Intern Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.3.5.701","article-title":"Amyloid a amyloidosis and systemic lupus erythematosus","volume":"3","author":"D\u00fczg\u00fcn","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0431-5","article-title":"AA Amyloidosis associated with systemic lupus erythematosus: impact on clinical course and outcome","volume":"28","author":"Aktas Yilmaz","year":"2008","journal-title":"Rheumatol Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.14971","article-title":"Renal amyloidosis in a patient with systemic lupus erythematosus","volume":"129","author":"Semik-Grabarczyk","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.152","article-title":"Leukocyte chemotactic factor 2: A novel renal amyloid protein","volume":"74","author":"Benson","year":"2008","journal-title":"Kidney Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.558","article-title":"Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis","volume":"86","author":"Said","year":"2014","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12882-020-01733-9","article-title":"Karyomegalic interstitial nephritis with a novel FAN1 gene mutation and concurrent ALECT2 amyloidosis","volume":"21","author":"Law","year":"2020","journal-title":"BMC Nephrol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfw147","article-title":"Mixed leukocyte cell-derived chemotaxin 2 and amyloid a renal amyloidosis in a Kazakh-German patient","volume":"10","author":"G\u00f6decke","year":"2017","journal-title":"Clin Kidney J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-609883","article-title":"A practical approach to the diagnosis of systemic amyloidoses","volume":"125","author":"Fernandez de Larrea","year":"2015","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-517938","article-title":"Leukocyte cell-derived chemotaxin 2 (LECT2)\u2013associated amyloidosis is a frequent cause of hepatic amyloidosis in the united states","volume":"123","author":"Mereuta","year":"2014","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.08.013","article-title":"Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series","volume":"56","author":"Murphy","year":"2010","journal-title":"Am J Kidney Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.966591\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T05:59:19Z","timestamp":1660888759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.966591\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2022.966591"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.966591","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"article-number":"966591"}}